Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database

Ítems similars

• Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events
  per: Sasaoka, Sayaka, et al.
  Publicat: (2016)
• Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
  per: Akiho Fukuda, et al.
  Publicat: (2017-01-01)
• Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
  per: Fukuda, Akiho, et al.
  Publicat: (2017)
• Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
  per: Matsui, Toshinobu, et al.
  Publicat: (2017)
• Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
  per: Hatahira, Haruna, et al.
  Publicat: (2018)